Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MERIT MEDICAL SYSTEMS INC
Report date August 10, 2022 · Filed August 12, 2022
Section 16 reporting ended · disclosed 2022-08-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 15,144 |
Ending reported balance
After 2022-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-08-10 · Exercise / conversion · Acquired 20,000 · Balance 35,144 Row 2 · 2022-08-10 · Sale · Disposed 20,000 · Balance 15,144 F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.05 to $62.24, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.05 · Expires 2023-01-28 | Direct | 0 |
Reported balance
After 2022-08-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-08-10 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Become exercisable in equal annual installments of 20% commencing 01/28/2017. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.25 · Expires 2028-03-19 | Direct | 9,681 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 9,681 F3: Become exercisable in equal annual installments of 25% commencing 03/19/2022. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.20 · Expires 2024-04-14 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 50,000 F4: Become exercisable in equal annual installments of 20% commencing 04/14/2018. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.80 · Expires 2025-03-02 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 40,000 F5: Become exercisable in equal annual installments of 20% commencing 03/02/2019. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.73 · Expires 2026-03-01 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 30,000 F6: Become exercisable in equal annual installments of 20% commencing 03/01/2020. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.71 · Expires 2027-02-26 | Direct | 16,722 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 16,722 F7: Become exercisable in equal annual installments of 25% commencing 02/26/2021. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.03 · Expires 2029-02-28 | Direct | 8,094 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 8,094 F8: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. |
| Common Stock, No Par ValueSEC Table I · non-derivative | IndirectBy 401(k) plan | 16,284 |
Reported balance
Holding disclosure · report date 2022-08-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 16,284 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.05 to $62.24, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2: Become exercisable in equal annual installments of 20% commencing 01/28/2017.
F3: Become exercisable in equal annual installments of 25% commencing 03/19/2022.
F4: Become exercisable in equal annual installments of 20% commencing 04/14/2018.
F5: Become exercisable in equal annual installments of 20% commencing 03/02/2019.
F6: Become exercisable in equal annual installments of 20% commencing 03/01/2020.
F7: Become exercisable in equal annual installments of 25% commencing 02/26/2021.
F8: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2022 Filed Aug 12, 2022 21:41 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0001415889-22-008567 · form4-08122022_020858.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 20,000 shares Expires 2023-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 01/28/2017. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 21:41 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 20,000 | $62.10 | $1,242,000.00 |
DisclosureSEC source: 0001415889-22-008567 · form4-08122022_020858.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,144 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.05 to $62.24, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 21:41 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 20,000 | $16.05 | $321,000.00 |
DisclosureSEC source: 0001415889-22-008567 · form4-08122022_020858.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:10 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 1,942 | $65.03 | $126,288.26 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,144 Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:10 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 8,094 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 Underlying: Common Stock · 8,094 shares Expires 2029-02-28 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:10 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 6,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,086 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 02/13/2016. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 11,887 | $61.82 | $734,854.34 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,456 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.71 to $61.96, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 20,000 | $17.27 | $345,400.00 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001631 · form4-03232021_060352.xml · derivative · entry 3 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F2 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing 03/19/2022. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 22:18 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,000 | $60.60 | $303,000.00 |
DisclosureSEC source: 0001415889-21-001576 · form4-03182021_030313.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 10/04/2015. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 25,000 | $59.58 | $1,489,500.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.93 to $59.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 25,000 | $12.06 | $301,500.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:17 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001203 · form4-03022021_040347.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:17 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001203 · form4-03022021_040347.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,315 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:28 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantPerformance Stock Units · Derivative | 7,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-027392 · a4.xml · derivative · entry 10 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,955 Underlying: Common Stock · 7,955 shares Expires 2023-03-15 F9 · derivative.exercise_price: Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria. F10 · shares: On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement. F11 · derivative.exercise_date: If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement. F11 · derivative.expiration_date: If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:28 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 16,722 | $0.00 Strike: $37.71 | $0.00 |
DisclosureSEC source: 0001104659-20-027392 · a4.xml · derivative · entry 9 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,722 Underlying: Common Stock · 16,722 shares Expires 2027-02-26 F8 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing 02/26/2021. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:20 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | PurchaseCommon Stock | 5,000 | $40.00 | $200,000.00 |
DisclosureSEC source: 0000856982-19-000102 · wf-form4_156460443839706.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:41 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000023 · wf-form4_155182930364882.xml · derivative · entry 7 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/01/2020. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,743 | $0.00 Strike: $13.14 | $0.00 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,743 shares Expires 2020-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing on 07/31/2014. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 4,743 | $61.30 | $290,745.90 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 4,743 | $13.14 | $62,323.02 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,257 | $0.00 Strike: $13.14 | $0.00 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,743 Underlying: Common Stock · 5,257 shares Expires 2020-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 07/31/2014. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,257 | $61.31 | $322,296.16 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.30 to $61.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 5,257 | $13.14 | $69,076.98 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:19 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 40,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003690 · edgar.xml · derivative · entry 7 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2025-03-02 F7 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 03/02/2019. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:10 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006049 · edgar.xml · derivative · entry 6 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-04-14 F6 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 04/14/2018. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 15,000 | $26.25 | $393,750.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 15,000 | $13.75 | $206,250.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.